Bristol-Myers Squibb Co. (BMY) News Headlines

▮ More

Date

Headline

6/2/2020 8:34:42 AM Bristol Myers : Phase 3 True North Trial On Ulcerative Colitis Meets Primary Endpoints

6/2/2020 7:58:23 AM Bristol Myers Reports Positive Topline Results From Pivotal Phase 3 True North Trial OfZeposia

6/1/2020 7:59:55 AM Compugen: FDA Allows Phase 1/2 Study Evaluating COM701 With BMS-986207 And Nivolumab

6/1/2020 7:08:06 AM Compugen: FDA Clears IND Application For Phase 1/2 Of COM701 With Bristol Myers Squibb's Opdivo And TIGIT Inhibitor

5/27/2020 7:38:39 AM European Commission Approves Bristol Myers' Zeposia - Quick Facts

5/27/2020 7:10:03 AM Bristol Myers Squibb Secures European Commission Approval For Zeposia

5/13/2020 11:15:21 PM FDA Snubs BMY And BLUE, Stocks That Moved On ASCO Abstracts (ARVN, CTMX, MGNX)

5/12/2020 7:10:45 AM GRYT Health And Bristol Myers Squibb Team Up To Launch COVID Advocacy Exchange For Patient Advocates

5/7/2020 8:18:29 AM Bristol-Myers Squibb Co. Q1 adjusted earnings Beat Estimates

5/7/2020 8:18:09 AM Bristol-Myers Q1 Results Beat View; Cuts 2020 GAAP Profit Outlook

5/7/2020 7:03:54 AM Bristol Myers Squibb Q1 GAAP Loss/Shr $0.34 And Non-GAAP EPS $1.72

5/6/2020 11:33:38 PM FDA Decision On BMY's Drug Postponed, ENTA's PBC Study Fails, MGNX Turns Heads

4/21/2020 1:39:42 AM CYCC In STOPCOVID, EXEL Hits New High, NVS Trialing Malaria Drug For COVID-19

4/8/2020 11:13:49 PM BMY Awaits FDA Decision, LQDA On Watch, MNOV To Begin Clinical Trial In COVID-19

4/7/2020 7:07:12 AM Bristol Myers Squibb Expenads Existing Patient Support Programs To help Eligible Unemployed Patients In The U.S.

4/6/2020 3:16:17 AM New Drugs Approved In The Month Of March

3/27/2020 1:44:44 AM U.S. Now Has Most Virus Cases, BSGM To Develop COVID-19 Drug, FDA Nod For BMY

3/25/2020 9:05:57 AM BeiGene: NMPA Suspended Importation, Sales And Use Of ABRAXANE In China

3/18/2020 3:26:43 AM Oxford Biomedica Signs License, Clinical Supply Agreement With Juno Therapeutics

3/3/2020 6:01:02 PM Voluntis And Bristol-Myers Squibb To Co-Develop Digital Therapeutics For Oncology